3D bioprinting is a biofabrication method that deposits cells, biomaterials, and bioactive molecules layer by layer to create three-dimensional biological structures. It uses bioinks, printing hardware, computer-aided design, and controlled curing or crosslinking to place living components with spatial precision. In biotechnology and nanomedicine, 3D bioprinting is used to build tissue models, scaffolds, organ-on-chip components, disease models, and regenerative constructs.
3D bioprinting matters because tissue function depends strongly on architecture, cell distribution, matrix composition, and vascular-like transport. Research targets skin, cartilage, bone, liver, heart, neural tissue, tumors, and vascular networks. Key challenges include bioink design, cell viability, printing resolution, mechanical strength, maturation, vascularization, and reproducibility. Nanomaterials can improve rheology, conductivity, stiffness, bioactivity, and controlled release. The field connects closely to biofabrication, tissue engineering, hydrogels, and scaffolds.
Conferences on 3D bioprinting appear in biofabrication, regenerative medicine, tissue engineering, biomaterials, biotechnology, and medical-device programs. Sessions often cover bioinks, printer technologies, vascularization, organ models, high-throughput printing, and translation. Tracking bioprinting events helps researchers follow one of the most visible manufacturing routes for engineered living tissues.
To learn more, read our detailed glossary article on 3d bioprinting.